Search Results - "on behalf of the J-ROCKET AF study investigators"
-
1
Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation: The J-ROCKET AF Study
Published in Circulation Journal (2012)“…Background: The global ROCKET AF study evaluated once-daily rivaroxaban vs. warfarin for stroke and systemic embolism prevention in patients with atrial…”
Get full text
Journal Article -
2
Rivaroxaban vs. Warfarin in Japanese Patients With Non-Valvular Atrial Fibrillation in Relation to Age: Insight From J-ROCKET AF
Published in Circulation Journal (2014)“…Background: The J-ROCKET AF study found that rivaroxaban was non-inferior to warfarin with respect to the principal safety outcome in patients with atrial…”
Get full text
Journal Article -
3
Safety and Efficacy of Adjusted Dose of Rivaroxaban in Japanese Patients With Non-Valvular Atrial Fibrillation: Subanalysis of J-ROCKET AF for Patients With Moderate Renal Impairment
Published in Circulation Journal (2013)“…Background: In the Japanese Rivaroxaban Once-daily oral direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism…”
Get full text
Journal Article -
4
Point-of-Care Device for Warfarin Monitoring Used in the J-ROCKET AF Study
Published in Circulation Journal (25-05-2016)Get full text
Journal Article